Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Safety and Feasibility of Ayurvedic Oral Cannabis Preparation in the Peri-operative Period in Breast and Oral Cavity Squamous Cell Cancer

NCT05969314 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.

NCT NCT05969314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05969314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Safety and Feasibility of Ayurvedic Oral Cannabis Preparation in the Peri-operative Period in Breast and Oral Cavity Squamous Cell Cancer
Lead sponsor
Tata Memorial Hospital
Phase
Phase 1
Overall status
Active, not recruiting
Start date
June 8, 2022
Completion date
December 30, 2026
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, oral cancer